Capital Advantage, Inc. Pfizer Inc Transaction History

Capital Advantage, Inc.

$496 Million
Q1 2024

A detailed history of Capital Advantage, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Capital Advantage, Inc. holds 22,013 shares of PFE stock, worth $617,464. This represents 0.12% of its overall portfolio holdings.

Number of Shares

22,013

Previous 22,245 1.04%

Holding current value

$617,464

Previous $640,000 4.69%

% of portfolio

0.12%

Previous 0.13%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $6,006 - $6,897	-232 Reduced 1.04%	22,013 $610,000
Q4 2023 Jan 22, 2024	SELL	$26.13 - $33.94 $73,817 - $95,880	-2,825 Reduced 11.27%	22,245 $640,000
Q3 2023 Oct 30, 2023	BUY	$32.09 - $37.51 $16,301 - $19,055	508 Added 2.07%	25,070 $831,000
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $8,488 - $9,820	-235 Reduced 0.95%	24,562 $900,000
Q1 2023 May 04, 2023	BUY	$39.39 - $51.28 $34,781 - $45,280	883 Added 3.69%	24,797 $1.01 Million

Q4 2022 Jan 23, 2023	SELL	$41.75 - $54.5 $3,047 - $3,978	-73 Reduced 0.3%	23,914 $0
Q3 2022 Oct 31, 2022	BUY	$43.76 - $53.42 $85,375 - $104,222	1,951 Added 8.85%	23,987 $1.05 Million
Q2 2022 Jul 21, 2022	SELL	$46.53 - $55.17 $37,084 - $43,970	-797 Reduced 3.49%	22,036 $1.16 Million
Q1 2022 May 10, 2022	BUY	$45.75 - $56.69 $36,188 - $44,841	791 Added 3.59%	22,833 $1.18 Million
Q4 2021 Jan 21, 2022	BUY	$41.32 - $61.25 $20,907 - $30,992	506 Added 2.35%	22,042 $1.19 Million
Q3 2021 Oct 07, 2021	BUY	$39.25 - $50.42 $1,766 - $2,268	45 Added 0.21%	21,536 $926,000
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $430 - $488	-12 Reduced 0.06%	21,491 $842,000
Q1 2021 Apr 26, 2021	BUY	$33.49 - $37.77 $58,205 - $65,644	1,738 Added 8.79%	21,503 $779,000
Q4 2020 Feb 17, 2021	BUY	$33.47 - $42.56 $11,781 - $14,981	352 Added 1.81%	19,765 $735,000
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $2,698 - $3,166	-85 Reduced 0.44%	19,413 $708,000
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $8,283 - $10,048	-275 Reduced 1.39%	19,498 $638,000
Q1 2020 May 08, 2020	BUY	$27.03 - $38.62 $47,329 - $67,623	1,751 Added 9.72%	19,773 $730,000
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $18,994 - $21,556	-577 Reduced 3.1%	18,022 $718,000
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $71,737 - $93,023	2,208 Added 13.47%	18,599 $668,000
Q1 2019 May 10, 2019	BUY	$37.5 - $41.2 $56,100 - $61,635	1,496 Added 10.04%	16,391 $696,000
Q4 2018 Feb 07, 2019	BUY	$38.47 - $43.86 $3,231 - $3,684	84 Added 0.57%	14,895 $650,000
Q3 2018 Nov 01, 2018	SELL	$34.47 - $41.81 $16,097 - $19,525	-467 Reduced 3.06%	14,811 $653,000
Q2 2018 Aug 01, 2018	SELL	$32.98 - $35.16 $25,889 - $27,600	-785 Reduced 4.89%	15,278 $554,000
Q1 2018 May 02, 2018	BUY	$31.91 - $37.02 $382 - $444	12 Added 0.07%	16,063 $570,000
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $332 - $352	10 Added 0.06%	16,051 $581,000
Q3 2017 Oct 30, 2017	SELL	$31.0 - $34.15 $261,144 - $287,679	-8,424 Reduced 34.43%	16,041 $573,000
Q2 2017 Aug 08, 2017	BUY	N/A	24,465	24,465 $822,000

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advantage, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital Advantage, Inc. with notifications on news.

Account

Capital Advantage, Inc. Pfizer Inc Transaction History